resazurin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jha, AB; Panchal, SS; Shah, A | 1 |
| Burton, MA; Duong, S; Goldstein, LE; Hyman, B; Ingelsson, M; Kirby, JE; Moir, RD; Soscia, SJ; Tanzi, RE; Tucker, SM; Washicosky, KJ | 1 |
2 other study(ies) available for resazurin and Alzheimer Disease
| Article | Year |
|---|---|
Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Cognition; Donepezil; Ellagic Acid; Female; Free Radical Scavengers; Humans; Male; Maze Learning; Molecular Docking Simulation; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Xanthenes | 2018 |
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antimicrobial Cationic Peptides; Brain; Candida albicans; Cathelicidins; Cell Survival; Environment; Humans; Immunity, Innate; Inflammation; Ligands; Microbial Sensitivity Tests; Oxazines; Recombinant Proteins; Xanthenes | 2010 |